Skip to Content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Health Highlights: June 14, 2021

AMA's Plan to Fight Racism Criticized by Some Members The American Medical Association is facing backlash from some of its members over a plan to fight racism...

Weight-Loss Surgeries Used Least in U.S. States That Need Them Most

MONDAY, June 14, 2021 -- The American South and Midwest are home to the highest obesity rates in the nation, but a new study reveals that severely obese...

Good News, Bad News From Alzheimer's Vaccine Trial

MONDAY, June 14, 2021 -- An experimental Alzheimer's vaccine appears to safely clear abnormal tau protein from the brain, but it's not yet clear whether the...

2008 to 2018 Saw Decrease in Pediatric Inpatient Capacity

MONDAY, June 14, 2021 -- From 2008 to 2018, there was a decrease in pediatric inpatient capacity and an increase in pediatric intensive care unit (PICU) beds,...

NSAIDs Better Than Codeine for Outpatient Postoperative Pain

MONDAY, June 14, 2021 -- For adult outpatients, use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with better pain scores and better global...

Young Adults Who Restore Heart Health Cut Later CVD Risk

MONDAY, June 14, 2021 -- Poor cardiovascular health in young adulthood is associated with subsequent cardiovascular disease (CVD), but improving cardiovascular...

AHA News: U.S. Appears to Lose Ground in Controlling High Blood Pressure

MONDAY, June 14, 2021 (American Heart Association News) -- After years of improvement, high blood pressure control in the U.S. dropped regardless of age, race...

Most U.S. Adults Do Not Eat Enough Dietary Fiber

MONDAY, June 14, 2021 -- Few U.S. adults regularly eat enough dietary fiber, according to a study presented during Nutrition 2021, the annual meeting of the...

Risk for Adverse Events Not Increased After COVID-19 Vaccine in IBD

MONDAY, June 14, 2021 -- Individuals with inflammatory bowel disease (IBD) do not have an increased risk for adverse events (AEs) after the mRNA COVID-19...

Most Editors at Leading Medical Journals Are White, Study Finds

MONDAY, June 14, 2021 -- The vast majority of editors at leading medical journals are white — with few of those influential spots going to Black or...

U.S. Food and Drug Administration Approves New Formulation of Epclusa, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C

FOSTER CITY, Calif.--(BUSINESS WIRE)--Jun. 10, 2021-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the U.S. Food and Drug Administration (FDA) has...

Vertex Announces U.S. FDA Approval for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations

BOSTON--(BUSINESS WIRE)--Jun. 9, 2021-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved...

FDA Approves Prevnar 20 (pneumococcal 20-valent conjugate vaccine) for Adults Ages 18 Years or Older

First approval of a conjugate vaccine that helps protect against 20 serotypes responsible for the majority of invasive pneumococcal disease and...

FDA Grants Accelerated Approval for Aduhelm (aducanumab-avwa) for the Treatment of Alzheimer’s Disease

CAMBRIDGE, Mass. and TOKYO, June 07, 2021 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced that the U.S. Food and...

Alexion Announces FDA Approval of Ultomiris (ravulizumab-cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)

BOSTON--(BUSINESS WIRE)--Jun. 7, 2021-- Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the U.S. Food and Drug Administration (FDA) has approved...

CTI BioPharma Announces Acceptance of NDA Granted with Priority Review of Pacritinib for Treatment of Patients with Myelofibrosis

SEATTLE, June 1, 2021 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New...

Akebia and Otsuka Announce FDA Acceptance for Filing of New Drug Application for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis and Not on Dialysis

CAMBRIDGE, Mass. and TOKYO, June 1, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering...

Mycovia Pharmaceuticals Submits New Drug Application to the U.S. FDA for Oteseconazole for the Treatment of Recurrent Vulvovaginal Candidiasis

DURHAM, N.C.--(BUSINESS WIRE) June 01, 2021 -- Mycovia Pharmaceuticals, Inc. (“Mycovia”), an emerging biopharmaceutical company dedicated to...

Fennec Pharmaceuticals Resubmits New Drug Application To U.S. Food And Drug Administration For Pedmark

Research Triangle Park, NC, May 28, 2021 – Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company, today announced the...

TG Therapeutics Announces FDA Acceptance of Biologics License Application for Ublituximab in Combination with Ukoniq (umbralisib) as a Treatment for Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that the U.S. Food and Drug Administration (FDA) has accepted...

New Pivotal Data at EHA 2021 Reinforces Sutimlimab as a First-in-Class Investigational C1s Inhibitor with the Potential to be the First Approved Treatment for Hemolysis in People with Cold Agglutinin Disease

PARIS – June 11, 2021 – Results from Part A of CADENZA, a pivotal Phase 3 double-blind, placebo-controlled study evaluating the safety and efficacy...

Merck Announces Supply Agreement with U.S. Government for Molnupiravir, an Investigational Oral Antiviral Candidate for Treatment of Mild to Moderate COVID-19

KENILWORTH, N.J.--(BUSINESS WIRE) June 9, 2021 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it has entered into a...

FDA Authorizes Lower 1,200 mg Intravenous and Subcutaneous Dose of REGEN-COV™ (casirivimab and imdevimab) Antibody Cocktail to Treat Patients with COVID-19

TARRYTOWN, N.Y., June 4, 2021 /PRNewswire/ -- EUA supported by pivotal Phase 3 data showing 1,200 mg dose reduced risk of hospitalization or death by...

Phase 2 Fight Trial Continues To Show Improved Overall Survival With Bemarituzumab Plus Chemotherapy In Patients With FGFR2b+ Gastric And Gastroesophageal Cancers

THOUSAND OAKS, Calif., June 4, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced updated results for investigational bemarituzumab in combination with...

Novartis Investigational Checkpoint Inhibitor Tislelizumab Met Primary Endpoint of Overall Survival in Pivotal Phase III Trial of Esophageal Cancer After Systemic Therapy

EAST HANOVER, N.J., June 4, 2021 -- Novartis announced today results from the pivotal Phase III RATIONALE 302 trial showing the investigational anti-PD-1...

Browse by News Type

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.